NCT06733766Recruiting
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer: A Multicenter Study
Source: ClinicalTrials.gov · Last updated 14 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for recurrent thyroid cancer
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 7 Dec 2024
- Start date
- 9 Dec 2024
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Chinese PLA General Hospital
- Diseases
- Thyroid cancer
- NCT number
- NCT06733766
What you commit to
- Study type: Observational
- Planned participants: 300
- From 9 Dec 2024 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- coagulation disorder, serious heart, respiratory, liver, or renal failure
Other
- dysfunction of the vocal cord on the opposite side
Who the study is looking for
- patient received thyroidectomy for thyroid cancer
- recurrent lesions were pathologically proven to be malignant by core-needle biopsy or fine needle aspiration
- no evidence of distant metastases.
- follow-up period ≥12 months
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese PLA General Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.